Apellis Pharmaceuticals APLS 深 滬
已收盤 09-05 16:00:00 美东时间
28.13
-0.520
-1.82%
華盛通- 最 高28.97
- 今 開28.84
- 成交量 281.01万股
- 最 低 27.845
- 昨 收 28.65
- 總市值 35.44亿
- 52周最高 37.835
- 市盈率 靜 --
- 換手率 2.23%
- 52周最低 16.10
- 委 比 0.08%
- 總股本 1.26亿
- 歷史最高 94.75
- 量 比 1.47
- 振 幅 3.93%
- 歷史最低 11.45
- 每 手 1
- 風險率 5.93%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Anaptys Announces Participation in September Investor Conferences
AnaptysBio, a clinical-stage biotechnology company, announced that its executives will attend three investor conferences: the Cantor Global Healthcare Conference on Sept. 3, the Wells Fargo Healthcare Conference on Sept. 4, and the Stifel Virtual Immunology and Inflammation Forum on Sept. 16. Each event will feature fireside chats and one-on-one meetings. The company focuses on immunology therapeutics, with a lead program, rosnilimab, in Phase 2 ...
08-27 20:15
Apellis Pharmaceuticals to Participate in Upcoming Investor Conferences
Apellis Pharmaceuticals, Inc. announced that its management will participate in webcast fireside chats at three investor conferences: the Wells Fargo Healthcare Conference on September 3, 2025, the Cantor Global Healthcare Conference on September 4, 2025, and the Baird Global Healthcare Conference on September 9, 2025. Live webcasts and replays will be available on the company’s website. The company, a leader in complement science, has developed ...
08-27 11:00
What to Expect from Kymera Therapeutics's Earnings
Kymera Therapeutics (NASDAQ:KYMR) is gearing up to announce its quarterly earni...
08-08 23:01
美股大行评级 | 花旗、小摩分别上调苹果目标价；瑞穗上调Robinhood目标价从99美元升至120美元
今日重点评级关注：花旗：维持Apellis Pharmaceuticals"买入"评级，目标价从46美元升至52美元；BTIG：维持Strategy"买入"评级，目标价从620美元升至700美元
08-04 09:30
Raymond James Maintains Outperform on Apellis Pharmaceuticals, Lowers Price Target to $50
Raymond James analyst Ryan Deschner maintains Apellis Pharmaceuticals (NASDAQ:APLS) with a Outperform and lowers the price target from $52 to $50.
08-01 21:20
Roblox, Carvana, eBay, C.H. Robinson Worldwide, Huntington Ingalls Industries And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Nasdaq Composite gaining around 150 points on...
07-31 23:00
Apellis Pharmaceuticals Q2 EPS $(0.33) Beats $(0.48) Estimate, Sales $178.494M Miss $187.790M Estimate
Apellis Pharmaceuticals (NASDAQ:APLS) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.48) by 31.25 percent. This is a 10 percent decrease over losses of $(0.30) per share
07-31 18:56
Earnings Scheduled For July 31, 2025
Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (...
07-31 16:32
Here are the major earnings before the open Thursday
Major earnings expected before the bell on Thursday include: AbbVie (OTC:ABBY) Bristol-Myers Squibb Company (BMY) Mastercard Incorporated (MA) CVS Health Corporation (CVS) Shell plc (SHEL) Other earni...
07-31 06:00
美股大行评级 | 潜在涨幅36%！花旗上调Coinbase目标价升至505美元；摩根大通维持迪士尼"超配"评级，目标价升至138美元
今日重点评级关注：花旗：维持Apellis Pharmaceuticals"买入"评级，目标价从41美元升至46美元；杰富瑞：维持Kiniksa Pharmaceuticals"买入"评级，目标价从45美元升至54美元
07-30 09:36
